Suppr超能文献

《生物制剂的成本变异性》

The Cost Variability of Orthobiologics.

机构信息

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Alabama College of Osteopathic Medicine, Dothan, Alabama.

出版信息

Sports Health. 2020 Jan/Feb;12(1):94-98. doi: 10.1177/1941738119880256. Epub 2019 Oct 30.

Abstract

BACKGROUND

Mixed results exist regarding the benefit of orthobiologic injections. The purpose of this study was to assess the variability in costs for platelet-rich plasma (PRP) and stem cell (SC) injections and evaluate for variables that influence pricing.

HYPOTHESIS

There will be significant variability in the cost of PRP and SC injections throughout the United States.

STUDY DESIGN

Descriptive epidemiology study.

LEVEL OF EVIDENCE

Level 3.

METHODS

Calls were made to 1345 orthopaedic sports medicine practices across the United States inquiring into the availability of PRP or SC knee injections and associated costs. In addition to pricing, the practice type, number of providers, and population and income demographics were recorded. Univariate statistical analyses were used to identify differences in availability and cost between variables.

RESULTS

Of the contacted offices that provided information on both PRP and SC availability (n = 1325), 268 (20.2%) offered both treatments, 550 (41.5%) offered only PRP injections, 20 (1.5%) offered only SC injections, and 487 (36.8%) did not offer either treatment. The mean ± SD cost of a PRP injection was $707 ± $388 (range, $175-$4973), and the mean cost of an SC injection was $2728 ± $1584 (range, $300-$12,000). Practices offering PRP and SC injections tended to be larger (PRP, 12.0 physicians per practice vs. 8.1 [ < 0.001]; SC, 13.6 vs 9.7 [ < 0.001]). Practices that offered PRP injections were located in areas with higher median household income ( = 0.047). Variables associated with higher cost of PRP injections included city population ( < 0.001) and median income of residents ( < 0.001).

CONCLUSION

While the majority of sports medicine practices across the United States offer some type of orthobiologic injection, there exists significant variability in the cost of these injections.

CLINICAL RELEVANCE

This study demonstrates the significant variability in costs of orthobiologic injections throughout the country, which will allow sports medicine physicians to appreciate the value of these injections when counseling patients on available treatment options.

摘要

背景

关于骨生物学注射的益处,结果喜忧参半。本研究旨在评估富血小板血浆(PRP)和干细胞(SC)注射的成本差异,并评估影响定价的变量。

假设

全美范围内 PRP 和 SC 注射的成本存在显著差异。

研究设计

描述性流行病学研究。

证据水平

3 级。

方法

向全美 1345 家骨科运动医学诊所致电,询问 PRP 或 SC 膝关节注射的可用性及其相关费用。除了价格外,还记录了诊所类型、提供者人数以及人口和收入情况。使用单变量统计分析来确定变量之间可用性和成本的差异。

结果

在所联系的提供 PRP 和 SC 可用性信息的办公室中(n = 1325),268 个(20.2%)提供了两种治疗方法,550 个(41.5%)仅提供 PRP 注射,20 个(1.5%)仅提供 SC 注射,487 个(36.8%)未提供任何一种治疗。PRP 注射的平均±SD 费用为 707 ± 388 美元(范围为 175-4973 美元),SC 注射的平均费用为 2728 ± 1584 美元(范围为 300-12000 美元)。提供 PRP 和 SC 注射的诊所往往规模较大(PRP:每个诊所 12.0 名医生 vs. 8.1 [ < 0.001];SC:13.6 名 vs. 9.7 [ < 0.001])。提供 PRP 注射的诊所位于中位数家庭收入较高的地区(= 0.047)。与 PRP 注射较高费用相关的变量包括城市人口(<0.001)和居民中位数收入(<0.001)。

结论

尽管全美大多数运动医学诊所都提供某种类型的骨生物学注射,但这些注射的费用存在显著差异。

临床相关性

本研究表明,全国范围内骨生物学注射的成本存在显著差异,这将使运动医学医生在为患者提供可用治疗方案的咨询时了解这些注射的价值。

相似文献

1
The Cost Variability of Orthobiologics.
Sports Health. 2020 Jan/Feb;12(1):94-98. doi: 10.1177/1941738119880256. Epub 2019 Oct 30.
2
There Is Wide Variation in Platelet-rich Plasma Injection Pricing: A United States Nationwide Study of Top Orthopaedic Hospitals.
Clin Orthop Relat Res. 2024 Apr 1;482(4):675-684. doi: 10.1097/CORR.0000000000002864. Epub 2023 Oct 9.
3
Stem Cells and Platelet-rich Plasma for Knee Osteoarthritis: Prevalence and Cost in South Florida.
J Am Acad Orthop Surg. 2019 Oct 15;27(20):779-783. doi: 10.5435/JAAOS-D-18-00343.
4
Utilization of Orthobiologics by Sports Medicine Physicians: A Survey-based Study.
J Am Acad Orthop Surg Glob Res Rev. 2021 Jan 6;5(1):e20.00185. doi: 10.5435/JAAOSGlobal-D-20-00185.
6
Trends in utilization, demographics, and costs of platelet-rich plasma injections: a ten-year nationwide investigation.
Phys Sportsmed. 2024 Feb;52(1):89-97. doi: 10.1080/00913847.2023.2178816. Epub 2023 Feb 17.
7
The Cost-Effectiveness of Platelet-Rich Plasma Compared With Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis.
Arthroscopy. 2020 Dec;36(12):3072-3078. doi: 10.1016/j.arthro.2020.07.027. Epub 2020 Jul 25.
8
Platelet-Rich Plasma Intra-articular Knee Injections Show No Superiority Versus Viscosupplementation: A Randomized Controlled Trial.
Am J Sports Med. 2015 Jul;43(7):1575-82. doi: 10.1177/0363546515582027. Epub 2015 May 7.
9
Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts.
Knee Surg Sports Traumatol Arthrosc. 2021 Oct;29(10):3195-3210. doi: 10.1007/s00167-020-06102-5. Epub 2020 Jun 24.

引用本文的文献

1
Clinical Efficacy and Risks of Intradiscal Orthobiological Injections: A Narrative Review.
Curr Pain Headache Rep. 2025 Jul 11;29(1):99. doi: 10.1007/s11916-025-01414-y.
2
The Availability and Pricing of Orthobiologic Knee Injections in the Chicago Metropolitan Area: A Market Assessment Study.
Orthop J Sports Med. 2025 Jun 6;13(6):23259671241310452. doi: 10.1177/23259671241310452. eCollection 2025 Jun.
3
4
Mechanisms, Efficacy, and Clinical Applications of Platelet-Rich Plasma in Tendinopathy: A Comprehensive Review.
Cureus. 2024 Jul 29;16(7):e65636. doi: 10.7759/cureus.65636. eCollection 2024 Jul.
5
Public Interest in Shoulder Platelet-Rich Plasma Injections Is Increasing: A 10-Year Google Trends Analysis.
Arthrosc Sports Med Rehabil. 2023 Jul 13;5(4):100744. doi: 10.1016/j.asmr.2023.04.026. eCollection 2023 Aug.
8
Assessment of Characteristics and Methodological Quality of the Top 50 Most Cited Articles on Platelet-Rich Plasma in Musculoskeletal Medicine.
Orthop J Sports Med. 2022 May 26;10(5):23259671221093074. doi: 10.1177/23259671221093074. eCollection 2022 May.
9
Anterior Cruciate Ligament Reconstruction: Is Biological Augmentation Beneficial?
Int J Mol Sci. 2021 Nov 22;22(22):12566. doi: 10.3390/ijms222212566.

本文引用的文献

3
Health Care Spending in the United States and Other High-Income Countries.
JAMA. 2018 Mar 13;319(10):1024-1039. doi: 10.1001/jama.2018.1150.
4
Drivers of Hospital Costs in the Self-Pay Facelift (Rhytidectomy) Patient: Analysis of Hospital Resource Utilization in 1890 Patients.
Aesthetic Plast Surg. 2018 Apr;42(2):603-609. doi: 10.1007/s00266-017-0984-y. Epub 2017 Nov 3.
6
The Stem-Cell Market for the Treatment of Knee Osteoarthritis: A Patient Perspective.
J Knee Surg. 2018 Jul;31(6):551-556. doi: 10.1055/s-0037-1604443. Epub 2017 Jul 24.
7
Stem cell injections in knee osteoarthritis: a systematic review of the literature.
Br J Sports Med. 2017 Aug;51(15):1125-1133. doi: 10.1136/bjsports-2016-096793. Epub 2017 Mar 3.
8
Utilization of Platelet-Rich Plasma for Musculoskeletal Injuries: An Analysis of Current Treatment Trends in the United States.
Orthop J Sports Med. 2016 Dec 21;4(12):2325967116676241. doi: 10.1177/2325967116676241. eCollection 2016 Dec.
9
Platelet-Rich Plasma (PRP) in Orthopedic Sports Medicine.
Am J Orthop (Belle Mead NJ). 2016 Jul-Aug;45(5):290-326.
10
Efficacy of Intra-articular Platelet-Rich Plasma Injections in Knee Osteoarthritis: A Systematic Review.
Arthroscopy. 2016 Mar;32(3):495-505. doi: 10.1016/j.arthro.2015.08.005. Epub 2015 Oct 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验